Patients hospitalized with B.1.1.7 didn’t die at higher rates or have worse outcomes overall, a Lancet study finds.

from MarketWatch.com - Top Stories https://ift.tt/2QgSwMU
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2QgSwMU
via IFTTT
Kommentare
Kommentar veröffentlichen